112 related articles for article (PubMed ID: 19489538)
1. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).
Bagdanoff JT; Donoviel MS; Nouraldeen A; Carlsen M; Jessop TC; Tarver J; Aleem S; Dong L; Zhang H; Boteju L; Hazelwood J; Yan J; Bednarz M; Layek S; Owusu IB; Gopinathan S; Moran L; Lai Z; Kramer J; Kimball SD; Yalamanchili P; Heydorn WE; Frazier KS; Brooks B; Brown P; Wilson A; Sonnenburg WK; Main A; Carson KG; Oravecz T; Augeri DJ
J Med Chem; 2010 Dec; 53(24):8650-62. PubMed ID: 21090716
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate.
Yu XQ; Kramer J; Moran L; O'Neill E; Nouraldeen A; Oravecz T; Wilson AG
Xenobiotica; 2010 May; 40(5):350-6. PubMed ID: 20175664
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats.
Harris CM; Mittelstadt S; Banfor P; Bousquet P; Duignan DB; Gintant G; Hart M; Kim Y; Segreti J
J Pharmacol Exp Ther; 2016 Oct; 359(1):151-8. PubMed ID: 27519818
[TBL] [Abstract][Full Text] [Related]
6. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions.
Vogel P; Donoviel MS; Read R; Hansen GM; Hazlewood J; Anderson SJ; Sun W; Swaffield J; Oravecz T
PLoS One; 2009; 4(1):e4112. PubMed ID: 19119317
[TBL] [Abstract][Full Text] [Related]
7. Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression.
Zhao Y; Gorshkova IA; Berdyshev E; He D; Fu P; Ma W; Su Y; Usatyuk PV; Pendyala S; Oskouian B; Saba JD; Garcia JG; Natarajan V
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):426-35. PubMed ID: 21148740
[TBL] [Abstract][Full Text] [Related]
8. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
9. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
[TBL] [Abstract][Full Text] [Related]
10. Component of Caramel Food Coloring, THI, Causes Lymphopenia Indirectly via a Key Metabolic Intermediate.
Ohtoyo M; Machinaga N; Inoue R; Hagihara K; Yuita H; Tamura M; Hashimoto R; Chiba J; Muro F; Watanabe J; Kobayashi Y; Abe K; Kita Y; Nagasaki M; Shimozato T
Cell Chem Biol; 2016 May; 23(5):555-560. PubMed ID: 27185637
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren.
Bandhuvula P; Saba JD
Trends Mol Med; 2007 May; 13(5):210-7. PubMed ID: 17416206
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate lyase inhibition by 2-acetyl-4-(tetrahydroxybutyl)imidazole (THI) under conditions of vitamin B6 deficiency.
Ohtoyo M; Tamura M; Machinaga N; Muro F; Hashimoto R
Mol Cell Biochem; 2015 Feb; 400(1-2):125-33. PubMed ID: 25381637
[TBL] [Abstract][Full Text] [Related]
13. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
[TBL] [Abstract][Full Text] [Related]
14. Lyase to live by: sphingosine phosphate lyase as a therapeutic target.
Kumar A; Saba JD
Expert Opin Ther Targets; 2009 Aug; 13(8):1013-25. PubMed ID: 19534571
[TBL] [Abstract][Full Text] [Related]
15. Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.
Sanllehí P; Abad JL; Casas J; Bujons J; Delgado A
Bioorg Med Chem; 2016 Sep; 24(18):4381-4389. PubMed ID: 27475537
[TBL] [Abstract][Full Text] [Related]
16. Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.
Ohtoyo M; Tamura M; Machinaga N; Muro F; Hashimoto R
Lipids; 2016 Oct; 51(10):1207-1216. PubMed ID: 27585475
[TBL] [Abstract][Full Text] [Related]
17. A Bioassay Using a Pentadecanal Derivative to Measure S1P Lyase Activity.
Shin KO; Shamshiddinova M; Lee JN; Lee KS; Lee YM
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535437
[TBL] [Abstract][Full Text] [Related]
18. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
Pons G; Riba D; Casasampere M; Izquierdo E; Abad JL; Fabriàs G; Rodríguez Ortega PG; López-González JJ; Montejo M; Casas J; Delgado A
J Org Chem; 2020 Jan; 85(2):419-429. PubMed ID: 31860798
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol.
Ikeda M; Kihara A; Igarashi Y
Biochem Biophys Res Commun; 2004 Dec; 325(1):338-43. PubMed ID: 15522238
[TBL] [Abstract][Full Text] [Related]
20. Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice.
Weber C; Krueger A; Münk A; Bode C; Van Veldhoven PP; Gräler MH
J Immunol; 2009 Oct; 183(7):4292-301. PubMed ID: 19748984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
